Enhanced Seasonal Influenza Vaccine 2024-2025 (2025-2026, 2026-2027)

The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your tender for Enhanced Seasonal Influenza Vaccine for people who are in high risk for developing severe influenza. The contract period is one year (influenza season 2024- 2025). The procurement contains two contract period renewals to extend the contract period for the influenza seasons 2025-2026 and 2026-2027. Estimated quantity for the contract period including contract period renewals is 360.000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. Please note that all times given in the Call for tender refer to local time in Finland. Call for Tenders, annexes: Annex 1 Contract Annex 2 JYSE 2014 SUPPLIES (updated version of April 2022) Annex 3 Description of the Handi Service

The purpose of STM and the Customer is to procure Enhanced Seasonal Influenza Vaccine for risk groups required for the National Vaccination Programme in Finland. The tendered vaccine must be suitable for risk groups for severe influenza (for example elderly). Syringes without fixed needles are preferred. This procurement is not divided into separate lots. The vaccines are intended for the National Vaccination Programme for use by wellbeing services county and eventually municipalities and thus the need to coordinate the various contracting partners of separate lots could jeopardise the proper implementation of national immunization programme. More information about National Vaccination Programme and vaccinations can be found on the website of the Finnish Institute for Health and Welfare: https://thl.fi/en/web/infectious-diseases-and-vaccinations/vaccines-a-to-z/influenza-vaccine The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority". The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders. If the Supplier during the contract period releases an improved vaccine, the Parties may agree to substitute the Article with the improved vaccine. In case of substitution, all terms and prices in the Contract shall apply without modification. CONTRACT PERIOD Estimated quantity for the contract period is 120.000 doses for the influenza season 2024-2025. The customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. The Contract shall enter into a force once both parties have signed the Contract. However, the Contract period shall be counted from the first day of the month on which the Supplier has handed over the first delivery of the Articles to a pharmaceutical wholesaler with a contract with THL. The Contract shall expire when all contractual duties have been performed by both parties. After the contract period, the Customer reserves the right for the contract period renewals described in section "Description of renewals". Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tenders.

The purpose of STM and the Customer is to procure Enhanced Seasonal Influenza Vaccine for risk groups required for the National Vaccination Programme in Finland. The tendered vaccine must be suitable for risk groups for severe influenza (for example elderly). Syringes without fixed needles are preferred. This procurement is not divided into separate lots. The vaccines are intended for the National Vaccination Programme for use by wellbeing services county and eventually municipalities and thus the need to coordinate the various contracting partners of separate lots could jeopardise the proper implementation of national immunization programme. More information about National Vaccination Programme and vaccinations can be found on the website of the Finnish Institute for Health and Welfare: https://thl.fi/en/web/infectious-diseases-and-vaccinations/vaccines-a-to-z/influenza-vaccine The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority". The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders. CONTRACT PERIOD Estimated quantity for the contract period is 120.000 doses for the influenza season 2024-2025. The customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. The Contract shall enter into a force and the Contract period shall be counted from the first day of the month on which both of the following conditions are met: 1. The Contract has been signed by both parties, and 2. the Supplier has handed over the first delivery of the Articles to THL. The Contract shall expire when all contractual duties have been performed by both parties. After the contract period, the Customer reserves the right for the contract period renewals described in section "Description of renewals". Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tenders